P
PharmaResources Shanghai Co Ltd
SZSE:301230
PharmaResources Shanghai Co Ltd
SZSE:301230
Price:
45.21
CNY
-3.21%
Market Cap:
¥6.3B
Relative Value
The Relative Value of one PharmaResources Shanghai Co Ltd stock under the Base Case scenario is hidden CNY. Compared to the current market price of 45.21 CNY, PharmaResources Shanghai Co Ltd is hidden .
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
PharmaResources Shanghai Co Ltd Relative Value
HIDDEN
Multiples Across Competitors
Competitors Multiples
PharmaResources Shanghai Co Ltd Competitors
PharmaResources Shanghai Co Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CN |
P
|
PharmaResources Shanghai Co Ltd
SZSE:301230
|
6.2B CNY | 9.3 | 169.9 | 239.9 | 239.9 | |
| US |
P
|
PerkinElmer Inc
LSE:0KHE
|
1.1T USD | 376.9 | 4 462.5 | 1 414.8 | 3 022.9 | |
| US |
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
192.8B USD | 4.3 | 28.8 | 20.1 | 27 | |
| US |
|
Danaher Corp
NYSE:DHR
|
148.3B USD | 6 | 41 | 22.7 | 34.6 | |
| KR |
|
Samsung Biologics Co Ltd
KRX:207940
|
137.1T KRW | 14.6 | 50.2 | 50.7 | 67.5 | |
| CH |
|
Lonza Group AG
SIX:LONN
|
36.9B CHF | 5.7 | 39.4 | 28.8 | 28.8 | |
| CN |
|
WuXi AppTec Co Ltd
SSE:603259
|
291.5B CNY | 6.6 | 19.4 | 19.7 | 19.7 | |
| US |
|
Agilent Technologies Inc
NYSE:A
|
35.6B USD | 5.1 | 27.3 | 20 | 23.6 | |
| US |
|
IQVIA Holdings Inc
NYSE:IQV
|
28.3B USD | 1.7 | 20.7 | 11.6 | 17.4 | |
| US |
|
Mettler-Toledo International Inc
NYSE:MTD
|
28B USD | 6.9 | 32.1 | 23.7 | 26.3 | |
| CN |
|
WuXi Biologics (Cayman) Inc
HKEX:2269
|
164.5B HKD | 7.3 | 34.7 | 24.4 | 24.4 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
